CSBR vs PH · P/E 16, rev $56.9M vs P/E 28, rev $19.85B
Champions Oncology Inc (CSBR) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the CSBR and PH stock pages for the full models.
Not investment advice.